Winning Stock Forecast Ligand Pharmaceuticals Inc. (LGND). Returns up to 48.60% in 3 Months
Winning Stock Forecast Ligand Pharmaceuticals Inc. (LGND)
Our Winning Stock Forecast Ligand Pharmaceuticals Inc. (NASDAQ: LGND) is a mid-cap Biotech and Pharma company. The company has many programs of collaboration, in numbers, with 95 different Biotech and Pharmaceuticals companies including Baxter, Novartis, Pfizer and Bristol-Myers Squibb. Thanks to these collaborations, the company could arrive in 2020 to 24 new lines the product. However, shares have decreased about 14.9% since the last Earning report published in the end of September 2018. To confirm this, in mid-September price was $254.79 while the Average Volume for LGND shares was $344,030
